Daiwa Securities Group’s ALX Oncology ALXO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-138
| Closed | – | – | 1280 |
|
|
2024
Q3 | $0 | Hold |
138
| – | – | ﹤0.01% | 1277 |
|
|
2024
Q2 | $1K | Hold |
138
| – | – | ﹤0.01% | 1269 |
|
|
2024
Q1 | $2K | Hold |
138
| – | – | ﹤0.01% | 1250 |
|
|
2023
Q4 | $2K | Hold |
138
| – | – | ﹤0.01% | 1253 |
|
|
2023
Q3 | $1K | Hold |
138
| – | – | ﹤0.01% | 1228 |
|
|
2023
Q2 | $1K | Hold |
138
| – | – | ﹤0.01% | 1249 |
|
|
2023
Q1 | $1K | Hold |
138
| – | – | ﹤0.01% | 1230 |
|
|
2022
Q4 | $2K | Hold |
138
| – | – | ﹤0.01% | 1201 |
|
|
2022
Q3 | $1K | Hold |
138
| – | – | ﹤0.01% | 1259 |
|
|
2022
Q2 | $1K | Hold |
138
| – | – | ﹤0.01% | 1262 |
|
|
2022
Q1 | $2K | Hold |
138
| – | – | ﹤0.01% | 1232 |
|
|
2021
Q4 | $3K | Hold |
138
| – | – | ﹤0.01% | 1227 |
|
|
2021
Q3 | $10K | Buy |
138
+59
| +75% | +$4.28K | ﹤0.01% | 1132 |
|
|
2021
Q2 | $4K | Hold |
79
| – | – | ﹤0.01% | 1077 |
|
|
2021
Q1 | $6K | Buy |
79
+9
| +13% | +$684 | ﹤0.01% | 1065 |
|
|
2020
Q4 | $6K | Buy |
+70
| New | +$6K | ﹤0.01% | 1041 |
|